NCT05209737

Brief Summary

A pilot randomized controlled trial to evaluate the efficacy and safety of Trendelenburg position in critically ill patients with hypotension, mainly patients with septic shock and post operative vasoplegia. The main aim is to assess whether Trendelenburg position can improve organ function through a reduction in the need of fluid infusion and dose of vasopressors. Patients will be screened for participation in the study and eventually randomized based on a balanced randomization scheme (1:1) to Trendelenburg position up to 72 hours after intensive care unit (ICU) admission or Semirecumbent position (standard of care).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 27, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

January 31, 2022

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2025

Completed
Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

3.7 years

First QC Date

January 13, 2022

Last Update Submit

April 10, 2026

Conditions

Keywords

Trendelenburg positionhypotensionhypovolemic shockshockhead-down position

Outcome Measures

Primary Outcomes (1)

  • Time to severe hypotension resolution

    Time from randomization to timepoint in which MAP \> 65 mmHg not requiring fluids or vasoactive drugs (VIS \< 5), lasting \> 1 hour, in the semirecumbent position

    72 hours

Secondary Outcomes (8)

  • Ventilator-free days at 28 days

    28 days

  • ICU-free days at 28 days

    28 days

  • Restarting vasopressor/inotrope therapy

    28 days

  • 28-days mortality

    28 days

  • 90-days mortality

    90 days

  • +3 more secondary outcomes

Study Arms (2)

Trendelenburg position

EXPERIMENTAL

Position: 10-degree Head-down position

Procedure: Trendelenburg position

Semirecumbent position

ACTIVE COMPARATOR

Position: 30-degree Head-up position

Procedure: Semirecumbent position

Interventions

A 10-degree head-down position will be used in this group

Trendelenburg position

A 30-degree head-up position will be used in this group

Semirecumbent position

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years
  • Admitted to the intensive care unit (ICU);
  • Invasive mechanical ventilation;
  • Pharmacological sedation;
  • Mean arterial pressure (MAP)\<65 mmHg or need of fluids infusion or any vasopressor in order to keep MAP \> 65 mmHg
  • Ongoing invasive and/or non-invasive arterial blood pressure monitoring
  • Central venous line with central venous pressure (CVP) monitoring
  • Naso-gastric tube in situ
  • Indwelling bladder catheter
  • Consent according to local ethical committee rules

You may not qualify if:

  • Body mass index \> 45
  • Documented or suspected increased intracranial pressure, based on medical history or actual clinical condition (es. intracranial tumor, cerebral hemorrhage, encephalitis,...);
  • Intra-abdominal hypertension \>25 mmHg
  • Documented or suspected increased intraocular pressure (any degree of glaucoma)
  • Full stomach pyloric incontinence;
  • Gastric stasis, defined as aspiration from the NG (nasogastric) tube of fecal, bloody, or green fluid greater than 100 mL upon insertion of the tube or within the preceding hour;
  • Ongoing enteral nutrition
  • No central line inserted or femoral central line only
  • Not sutured known diaphragm lesions
  • Known hiatus hernia
  • Aortic bifurcation and/or lower extremity arterial stenosis ≥70% combined with stage 3 intermittent claudication (pain at rest)
  • Patients who are not able to be investigated with a leg raising test (eg lower extremities fractures, backbone fractures or backbone pain or deformity, and those patients with large cannulas in the femoral vessels)
  • Demand of specific postures (eg Trauma, fractures, backbone pain or deformity, patients with large cannulas in the femoral vessels, pronation including first pronation planned within 6 h…)
  • Any device which, according to the clinician, makes it unfeasible or unsafe to put patients in the Trendelenburg position (eg Drainage in thoracic cavity)
  • Mechanical Circulatory Support;
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Vishnevsky Center of Surgery

Moscow, 117997, Russia

Location

Demikhov Municipal Clinical Hospital 68

Moscow, Russia

Location

MeSH Terms

Conditions

HypotensionShock

Interventions

Head-Down Tilt

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Research V. Negovsky Reanimatology Research Institute

Study Record Dates

First Submitted

January 13, 2022

First Posted

January 27, 2022

Study Start

January 31, 2022

Primary Completion

October 20, 2025

Study Completion

November 20, 2025

Last Updated

April 15, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations